Targeting Poly (ADP) Ribose Polymerase I (PARP-1) and PARP-1 Interacting Proteins for Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 402-416

Bentham Science Publishers

Access to resources Recommend Favorite

XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADPribose) polymerase 1 inhibitor

By          

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1222-1228

Spandidos Publications

Access to resources Recommend Favorite

Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells

By            

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 1147-1152

Spandidos Publications

Access to resources Recommend Favorite

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells

By Arun Banu   Akar Ugur   Gutierrez-Barrera Angelica M.   Hortobagyi Gabriel N.   Ozpolat Bulent  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-07 ,pp. : 262-268

Spandidos Publications

Access to resources Recommend Favorite

Emodin attenuates radioresistance induced by hypoxia in HepG2 cells via the enhancement of PARP1 cleavage and inhibition of JMJD2B

By                      

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1691-1698

Spandidos Publications

Access to resources Recommend Favorite